STOCK TITAN
  1. Home
  2. Sec-filings
  3. SER
  4. [Form 4] Serina Therapeutics, Inc. Insider Trading Activity

[Form 4] Serina Therapeutics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock SER logo
Serina Therapeutics

NYSE:SER

SER Rankings

#5352 Ranked by Market Cap
N/A Ranked by Dividends

SER Latest News

Oct 8, 2025
Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors
Oct 6, 2025
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease
Sep 9, 2025
Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease
Sep 8, 2025
Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Aug 25, 2025
Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson’s Disease under 505(b)(2) NDA Pathway

SER Latest SEC Filings

Oct 6, 2025
[8-K] Serina Therapeutics, Inc. Reports Material Event
Sep 26, 2025
[DEF 14A] Serina Therapeutics, Inc. Definitive Proxy Statement
Sep 15, 2025
[PRE 14A] Serina Therapeutics, Inc. Preliminary Proxy Statement
Sep 15, 2025
[PRE 14A] Serina Therapeutics, Inc. Preliminary Proxy Statement
Sep 15, 2025
[8-K] Serina Therapeutics, Inc. Reports Material Event

SER Stock Data

54.69M
5.49M
62.09%
4.03%
2.1%
Biotechnology
Pharmaceutical Preparations
Link
United States
HUNTSVILLE